April 2014

India’s Pharma Non-Compliance Nightmare

FDA investigators expose India-based Sun Pharmaceuticals Industries for tampering with test data and a complete failure to maintain sanitary conditions in its laboratories. Inspectors encounter human waste, rodent traps, and manufacturing refuse at the plant, prompting a ban on US exports.

Glaxo Caught In Bribery Scandal….Again!

Despite promises to clean up its suspect drug promotion practices, GlaxoSmithKline sales reps have been charged with bribing Polish doctors to boost prescriptions of company products.

Sanitation Violations: Favourite Chains are Repeat Offenders

Anyone who has experienced a bout of food poisoning thinks twice about where they eat out. They peek into kitchens, scan dining rooms for cleanliness, scrutinize how often food handlers…
Read More

Pet Meds: Pharma’s New Drug Market

Within recent years, there’s been an explosion of pet-related products and vigorous marketing campaigns to promote them – gourmet foods, designer outerwear, luxurious accessories. Mainstream media has aggressively promoted pets…
Read More

Caffeine for the Prevention of Alzheimer’s Disease

Western medicine loves its pharmaceuticals. There are pills, injections, inhalers and patches for every conceivable ailment. It seems that each month brings a new drug delivery system to pharmacy shelves…
Read More

Big Pharma Collaborates to Improve Biological Targeting

It’s like owning the world’s first spaceship; an incredibly powerful and cutting-edge device capable of speeding across the universe. But there’s no guidance system. So, you end up either flying in circles, or colliding disastrously with an interstellar object. Many of the most innovative compounds that enter clinical trials suffer a similar fate.

“Synthetic” Livers Reduce Need for Lab Animals

Most of us, even those who wouldn’t call themselves pet-friendly, would love to see an end to animal lab testing. But the truth is, the practice remains central to our…
Read More